TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The purpose of this study is to investigate the safety and efficacy of TCRαβ+/CD19+ depleted allogeneic hematopoietic stem cell transplant (HSCT) for malignant and non-malignant disorders in children and adolescent/young adult patients using the CliniMACS® immunomagnetic selection device (Miltenyi Biotec).
Epistemonikos ID: 44823a9f3aaf2db9bc3837ca01f30d712d3fed35
First added on: May 22, 2024